news.cision.com

SECO TOOLS ABInterim report for the three months ended 31 March 2009- Revenue for the quarter fell by 28 per cent at fixed exchange rates and 17 per cent in Swedish kronor (SEK), and amounted to SEK 1,351 M (1,632).- First quarter profit was charged with one-time costs of SEK 29 M related to workforce reductions.- As a result of significantly decreased volumes, operating profit for the quarter declined to SEK 95 M (403).- Operating margin was 7.0 per cent (24.7).- Profit after tax was SEK 54 M (274).- Earnings per share were SEK 0.37 (1.89).Comments from the CEO“Seco Tools

Interim report January-March 2009

Submitted for publication at 10.a.m. on 28 April 2009Quarter Full year2009 2008 2008I IV I 2008Net turnover, 1 900 1 709 2 096 7 792MSEKEBITDA, MSEK 102 -35 337 796Operating -37 -165 214 289profit/lossMSEKOperating -2 -10 10 4margin, %Profit/loss -69 -222 180 124afterfinancialitems, MSEKNet profit/ -39 -98 130 152loss, MSEKEarnings per -0.76 -1.89 2.52 2.96share, SEKJanuary-March 2009 compared with same period in 2008• Net turnover was MSEK 1,900 (2,096), down 9%.• Net loss was MSEK -39 (130).• Earnings per share were SEK -0.76 (2.52).•

The Riksbank to offer new USD loans

The Riksbank will continue to hold auctions of loans in US dollars as existing loans mature. Auctions will be held on 6 May, 13 May and 24 June. The time to maturity for each of these loans will be approximately three months. Offered volumes in the auctions will be announced in connection with the publication of the complete terms and conditions.As in earlier auctions of US dollars, a minimum interest rate will be set. This will be linked to the expected policy rate in the United States. Complete terms and conditions will be announced two banking days prior to the auctions.

Anders Dahlvig proposed as new Chairman of the Board in New Wave Group AB (publ)

Tue, Apr 28, 2009 09:55 CET

The nomination committee proposes that Anders Dahlvig is elected new Chairman of the Board in New Wave Group at the Annual General Meeting (AGM), which takes place May 19, 2009 in Gothenburg.This means that the nomination committee's entire proposal to the Company's AGM is as follows: Re-election of Torsten Jansson and Mats Årjes as members and new election of Anders Dahlvig, Göran Harstedt, Kinna Bellander and Helle Kruse Nielsen as members with Anders Dahlvig as Chairman. No deputy board members suggested. Hans Johansson, Maria Andark and Peter Nilsson have declined re-election.Anders

Product from SCN Has Effect on the H1N1 Virus

In previous press releases, Scandinavian Clinical Nutrition (SCN) has described positive results from a study where the patented product Immulina has been tested against the influenza virus H1N1, which now has been tied to the swine flu.The study results showed that taking Immulina caused a significant reduction of both clinical symptoms and lung tissue damage after infection by the influenza virus H1N1, the cause of the new swine flu epidemic, compared to placebo. The study was conducted during 2008 at Louisiana State University in USA, and animal studies have also been conducted at

Annual General Meeting and Annual Report

Tue, Apr 28, 2009 09:16 CET

ContextVision hereby invites to Annual General Meeting on June 3rd in Stockholm. To access invitation, proxy and the Annual Report for 2008 please follow link belowhttp://www.contextvision.com/?id=5433Very welcome!

Lindab's Report for the First Quarter 2009 will be presented on 6 May 2009

Tue, Apr 28, 2009 09:14 CET

· Lindab's Interim Report will be made public on 6 May 2009 between 10.30 am and 11 am (CET). · A web cast telephone conference /95D7280A6B02E744C125758A003A247D?OpenDocument) will be held at 12:00 (CET). The report will be presented by David Brodetsky, President and CEO, and Nils Johan Andersson, CFO. · To access the telephone conference, please call UK +44 (0)20 7138 0824. · The presentation slides will be published on the Investor Relations section of the website http://www.lindabgroup.com/English/ir/

Atlas Copco utilizes mandates for repurchase and sale of own shares

Tue, Apr 28, 2009 08:46 CET

Stockholm, Sweden, April 28, 2009: The Board of Atlas Copco AB has decided to use the mandates granted by the Annual General Meeting for the repurchase and sale of shares at one or more occasions until the next AGM.The mandates cover repurchase of not more than 5 570 000 series A shares and the sale of not more than 1 445 000 series B shares on NASDAQ OMX Stockholm. Purchase and sale of shares can only be made at a price per share that falls within the registered price range at each given time.The purpose of repurchasing is to be able to fulfill the obligations under the Performance Stock

Report from Atlas Copco’s Annual General Meeting 2009

Tue, Apr 28, 2009 08:45 CET

Stockholm, Sweden, April 28, 2009: Atlas Copco AB yesterday held its Annual General Meeting, chaired by Sune Carlsson, Chair of the Board of Directors.The income statements and the balance sheets of the parent company and the Group were approved, together with the Board’s proposal for profit distribution.The proposed dividend of SEK 3.00 per share was approved. Record day for the dividend is April 30, 2009, and the dividend is estimated to be distributed by Euroclear Sweden AB on May 6, 2009.Nine Board members were elected: Sune Carlsson, Jacob Wallenberg, Staffan Bohman, Ulla Litzén,

HNA/HNB - Issue of commercial paper

Tue, Apr 28, 2009 08:45 CET

Hafslund ASA has issued a NOK 300 million commercial paper with maturity 30 April 2010, coupon 3.35 %. Hafslund ASA Oslo, 28 April 2009 For further information, please contact: Group Treasurer Ketil Wang, tel + 47 975 13 135

Issue of up to 18,500,000 new shares in a private placement

Tue, Apr 28, 2009 08:41 CET

Not for release, publication or distribution, directly or indirectly, in or intothe United States, Canada, Australia or Japan or in any jurisdiction in whichsuch transmission or distribution is unlawful. Any failure to comply with thisrestriction may constitute a violation of US, Canadian, Australian or Japanesesecurities laws or the securities laws of other states as the case may be. The Board of Directors of Vestas Wind Systems A/S has today resolved to offer upto 18,500,000 new shares of DKK 1.00 nominal value each through a privateplacement at market price using an accelerated

Konecranes delivers process cranes to iron ore mine in Australia

Tue, Apr 28, 2009 08:38 CET

In April 2009, Konecranes received an order for 16 process cranes from ChinaMetallurgical Group Corporation (MCC), the EPC contractor for the Sino Iron oreproject at Cape Preston in Western Australia. The Sino Iron project is ownedand managed by China based company CITIC Pacific Mining. The cranes will bedelivered in January 2010. The parties have agreed not to disclose the value ofthe order. Sino Iron is a magnetite iron ore project under construction in WesternAustralia. Once operational, it will be Australia's largest magnetite miningand processing operation, and one of the world'

Interim financial report, first quarter 2009

Tue, Apr 28, 2009 08:31 CET

- No. 1 in Modern Energy retains its forecast for 2009Summary: Vestas generated first-quarter revenue of EUR 1,105m, an increase of58 per cent, achieving an EBIT improvement of 124 per cent to EUR 76m andlifting the EBIT margin from 4.9 per cent to 6.9 per cent. Net working capitalstood at 8 per cent of expected annual revenue, against 2 per cent in Q1 2008.The increase was significantly attributable to larger inventories. The orderbacklog of firm and unconditional orders amounted to EUR 4.9bn at 31 March2009. Full-year expectations for 2009 are still for an EBIT margin of 11-13 per

Report from Annual General Meeting

At Vitrolife’s Annual General Meeting yesterday, April 27, the following, amongst other things, was decided:• The Board’s proposed dividend of SEK 0.40 for the financial year 2008 was approved. April 30, 2009 was adopted as the record day.• Re-election of Board members Patrik Tigerschiöld, Fredrik Mattsson, Madeleine Olsson-Eriksson, Semmy Rülf, Tord Lendau and Maris Hartmanis, in accordance with the election committee’s proposal.• In accordance with the proposal of the Board, to reduce the share capital by SEK 247,300 through the cancellation of 247,300 bought back shares and to

Interim Report January-March 2009

• Net operating income increased to SEK 348m (344), despite a fall in rental income to SEK 548m (561) due to net sales of properties • The surplus ratio increased to 64 per cent (61) • Earnings from property management activities grew by 10 per cent to SEK 148m (135) • The loss after changes in value and tax was SEK -81m (388) and earnings per share after dilution were SEK -0.49 (2.28) • Equity per share was SEK 57 (60) “By squeezing costs and streamlining our organisation, we improved the surplus ratio by 3 percentage points in the first quarter. The profit from property

Biovitrum Interim Report 1st January - 31st March, 2009

Strong revenues growth in the first quarter as an internationalpharmaceutical company January - March * Net revenues before license revenues increased by 78 percent compared to the same period 2008 and amounted to SEK 355.2 M (200.1). The increase is mainly a result of the sales of Kineret® and Kepivance®, from which revenues amounted to SEK 133.6 M (14.8). Total revenues from ReFacto® amounted to SEK 203.0 M (159.7).* Operating profit increased to SEK 12.0 M (-8.5).

COMPLETION OF THE LIFETREE ACQUISITION AND TECNOMEN'S DIVIDEND PAYMENT

Tue, Apr 28, 2009 08:15 CET

Tecnomen Corporation STOCK EXCHANGE RELEASE April 28, 2009, at 9.30 amCOMPLETION OF THE LIFETREE ACQUISITION AND TECNOMEN'S DIVIDEND PAYMENT Tecnomen announced on December 15, 2008 to have made an agreement on acquiring ashareholding of 96.6 % in the Indian company Lifetree Convergence Limited. Thisagreement included matters to be decided in a shareholders' meeting. These wereapproved in the Annual General Meeting on March 19, 2009. The authorities inIndia have also handled the acquisition and informed about the acceptance

REVENIO GROUP CORPORATION INTERIM REPORT Q1/2009: LOWER BUSINESS VOLUME IN THE SERVICES SEGMENT TRIMMED PROFITABILITY

Revenio Group CorporationStock exchange release April 28, 2009 at 9.15 a.m.REVENIO GROUP CORPORATION INTERIM REPORT Q1/2009Lower business volume in the services segment trimmed profitability - Consolidated net sales EUR 9.1 million (EUR 12.2 million), down by 25.6percent- Consolidated operating profit EUR -0.2 million (EUR 1.4 million),Or -2.3 percent of net sales (11.4 of net sales)- Pre-tax profit EUR -0.2 million (EUR 1.4 million)- Diluted and undiluted earnings per share EUR -0.002 (EUR 0.013)- Cash flow from operating activities EUR -0.4 million (EUR 0.9 million)-

PROXIES FOR EXTRAORDINARY GENERAL MEETING

Tue, Apr 28, 2009 08:07 CET

In connection with the Extraordinary General Meeting to be held on 4 May 2009, John Afseth - Chairman of the Board of Simtronics ASA, has on 27 April 2009 been assigned proxy based voting rights for 5 512 053 shares, equivalent to 7,94 per cent of the shares in the company.The proxies apply exclusively to the Extraordinary General Meeting in Simtronics ASA to be held on 4 May 2009.After receiving these proxies, John Afseth will represent 7 249 324 shares, representing 10,44 per cent of the share capital in the company.This information is subject of the disclosure requirements

Annual General Meeting in Acando

The following items were resolved at the Annual General Meeting of Shareholders of Acando AB (publ) held on April 27:Adoption and discharge from liability for the members of the Board of Directors and the Chief Executive OfficerThe Annual General Meeting (AGM) resolved the adoption of the Income Statement and Balance Sheet and the Consolidated Income Statement and Consolidated Balance Sheet. The AGM also resolved the appropriation of the Company's profits according to the adopted Balance Sheet. The AGM discharged the members of the Board of Directors and the Chief Executive Officer from

Prospectus for Trelleborg rights issue now available

The information in this press release is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong or Japan.For more information, please click this link:http://www.trelleborg.com/Rights-Issue-Prospectus

Interim report January-March 2009

January-March• Group revenues from sales of goods and royalties amounted to 339 (289) MSEK.• Earnings per share amounted to 0.42 (0.10) SEK.• Operating income amounted to 54 (10) MSEK.• Revenues within the Esthetics product area amounted to 269 (233) MSEK and operating income was 50 (55) MSEK.• Net income after tax amounted to 42 (10) MSEK.Important events after the end of the period• On April 22 Q-Med announced that Q-Med AB and Oceana Therapeutics, LCC., based in the US, have entered into global agreements regarding commercialization rights to Deflux® and Solesta™. The

Contract signed for new stores in Norrköping (Sweden) and Oslo (Norway)